PAM
NXTC icon

Panagora Asset Management’s NextCure NXTC Stock Holding History

Panagora Asset Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-280
Closed -$27K – 2165
2021
Q2 		$27K Sell
280
-343
-55% -$35.1K ﹤0.01% 2135
2021
Q1 		$75K Sell
623
-647
-51% -$93.7K ﹤0.01% 2101
2020
Q4 		$166K Sell
1,270
-276
-18% -$35.7K ﹤0.01% 1662
2020
Q3 		$163K Sell
1,546
-3,836
-71% -$472K ﹤0.01% 1592
2020
Q2 		$1.39M Buy
5,382
+5,366
+33,538% +$2.04M 0.01% 809
2020
Q1 		$7K Hold
16
– – ﹤0.01% 2205
2019
Q4 		$11K Hold
16
– – ﹤0.01% 2115
2019
Q3 		$6K Buy
+16
New +$5.2K ﹤0.01% 2255

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Panagora Asset Management's NXTC Position: Q3 2021 in Review

Panagora Asset Management sold out of NextCure (NXTC) in Q3 2021, closing a stake of 280 shares — an estimated $27K sold.

Panagora Asset Management first reported a position in NXTC in Q3 2019 and held it in 8 quarters. The position peaked at $1.39M in Q2 2020. 71 funds tracked by Wall St. Rank hold NXTC as of Q3 2021.

  • Panagora Asset Management reported no remaining NextCure position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 280 NextCure shares in Q3 2021, an estimated $27K.
  • Panagora Asset Management first reported a position in NextCure in Q3 2019 and held it in 8 quarters.
  • Panagora Asset Management's NextCure position peaked at $1.39M in Q2 2020.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.